Back to search
FDAFDA · Food and drugs·Recall number Z-0265-2025

Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.

Published November 6, 2024 · Recall initiated: September 5, 2024

Summary

FDA records medical device Class II recall Z-0265-2025, published November 6, 2024 and initiated September 5, 2024. Recalling firm: Beckman Coulter, Inc.; Status: Ongoing; Reported quantity: 465,481 kits; Lot: All IFU Part Numbers B14994, B63978, and A38168 affect all product/lots shipped from Jul-2021 to current; UDI-DI 15099590202910. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beckman Coulter, Inc.
Distributor
Distribution was made nationwide to the U.S., including Puerto Rico. There was government distribution but no military distribution. Foreign distribution was made to Mexico.
Lot
All IFU Part Numbers B14994, B63978, and A38168 affect all product/lots shipped from Jul-2021 to current; UDI-DI 15099590202910.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems. recalled?

Yes. FDA published recall Z-0265-2025 on November 6, 2024. Reported hazard: IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter